FDA inspection
Bristol-Myers Squibb Company: FDA inspection ending Dec 1, 2023
FDA inspection 1228554 · No Action Indicated (NAI) · New Brunswick, NJ
Key facts
| Inspection ID | 1228554 |
|---|---|
| Firm | Bristol-Myers Squibb Company |
| FEI number | 2211101 |
| Address | 1 Squibb Dr |
| City | New Brunswick |
| State | NJ |
| ZIP | 08901-1588 |
| Fiscal year | 2024 |
| Inspection end date | Dec 1, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data